ARDT (Ardent Health Partners, LLC) Stock Financials & Earnings | Market Cap Arena

ARDT (Ardent Health Partners, LLC) Stock Financials & Earnings | Market Cap Arena

ARDTArdent Health Partners, LLC

Mkt Cap$1B

Healthcare·Medical - Care Facilities·🇺🇸 United States·NYSE

Revenue (TTM)$6.3B

Net Income (TTM)$136M

EPS (TTM)$0.96

Free Cash Flow (TTM)$117M

Gross Margin58.0%

Op. Margin8.9%

Net Margin2.1%

FCF Margin1.8%

P/S Ratio (TTM)0.2x

P/E Ratio (TTM)9.3x

YoY Rev Growth+6.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$1.3B	$1.3B	$54M
Q2 23	$1.4B	$770M	$221M
Q3 23	$1.4B	$782M	$225M
Q4 23	$1.3B	$748M	$172M
Q1 24	$1.4B	$1.2B	$76M
Q2 24	$1.5B	$1.2B	-$157M
Q3 24	$1.4B	$1.2B	$70M
Q4 24	$1.6B	$952M	$337M
Q1 25	$1.5B	$1.2B	$67M
Q2 25	$1.6B	$1.4B	$137M
Q3 25	$1.6B	$900M	$254M
Q4 25	$1.6B	$154M	$107M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	0.3x	—
Q2 23	0.3x	—
Q3 23	0.2x	—
Q4 23	0.2x	23.5x
Q1 24	0.2x	16.5x
Q2 24	0.2x	14.7x
Q3 24	0.2x	13.8x
Q4 24	0.2x	6.0x
Q1 25	0.2x	5.6x
Q2 25	0.2x	5.0x
Q3 25	0.2x	6.2x
Q4 25	0.2x	9.3x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$22M	$1M
Q2 23	$43M	$10M
Q3 23	$89M	$64M
Q4 23	$67M	$10M
Q1 24	-$15M	-$39M
Q2 24	$118M	$79M
Q3 24	$92M	$49M
Q4 24	$120M	$38M
Q1 25	-$25M	-$48M
Q2 25	$117M	$71M
Q3 25	$152M	$93M
Q4 25	$0	$0

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$21M
Q2 23	$34M
Q3 23	$25M
Q4 23	$57M
Q1 24	$24M
Q2 24	$39M
Q3 24	$43M
Q4 24	$81M
Q1 25	$23M
Q2 25	$46M
Q3 25	$59M
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+33.0%	+46.3%
Q2 23	+38.3%	+33.0%
Q3 23	+26.5%	+11.1%
Q4 23	+23.2%	+12.9%
Q1 24	+9.3%	+7.9%
Q2 24	+7.5%	+41.9%
Q3 24	+5.2%	+19.7%
Q4 24	+19.3%	+8.1%
Q1 25	+4.0%	+4.9%
Q2 25	+11.9%	-7.4%
Q3 25	+8.8%	-4.1%
Q4 25	-0.1%	+18.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$360K	0.0%
Q2 23	$182K	0.0%
Q3 23	$181K	0.0%
Q4 23	$181K	0.0%
Q1 24	$512K	0.0%
Q2 24	$0	0.0%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$9M	0.6%
Q2 25	$11M	0.7%
Q3 25	$0	0.0%
Q4 25	$9M	0.6%

OpEx Breakdown

Quarter	G&A	S&M
Q1 23	$885M	—
Q2 23	$235M	$315M
Q3 23	$247M	$310M
Q4 23	$265M	$311M
Q1 24	$948M	—
Q2 24	$958M	—
Q3 24	$973M	—
Q4 24	$286M	$329M
Q1 25	$1.0B	—
Q2 25	$1.0B	—
Q3 25	$305M	$340M
Q4 25	$310M	—

Revenue Segments

Quarter	Reportable Segment
Q1 25	$1.5B
Q2 25	$1.6B

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 18	$99M	$0	$99M
Q3 18	$61M	$0	$61M
Q4 18	$60M	$0	$60M
Q4 23	$438M	$0	$438M
Q1 24	$373M	$0	$373M
Q2 24	$335M	$0	$335M
Q3 24	$563M	$0	$563M
Q4 24	$557M	$0	$557M
Q1 25	$495M	$0	$495M
Q2 25	$541M	$0	$541M
Q3 25	$609M	$0	$609M
Q4 25	$710M	$0	$710M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	143M	-69.8%
Q2 23	143M	-0.3%
Q3 23	141M	-1.3%
Q4 23	142M	+0.8%
Q1 24	143M	+0.8%
Q2 24	143M	-0.3%
Q3 24	138M	-3.7%
Q4 24	133M	-3.5%
Q1 25	141M	+6.0%
Q2 25	141M	+0.3%
Q3 25	141M	+0.1%
Q4 25	141M	+0.1%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 15	—	—
FY 16	—	—
FY 17	—	—
FY 18	—	—
FY 21	—	—
FY 22	—	—
FY 23	—	—
FY 24	$157K	38K
FY 25	$166K	38K